ALESSIO, ENZO
 Distribuzione geografica
Continente #
NA - Nord America 22.028
EU - Europa 13.229
AS - Asia 9.981
SA - Sud America 1.258
AF - Africa 250
Continente sconosciuto - Info sul continente non disponibili 29
OC - Oceania 25
Totale 46.800
Nazione #
US - Stati Uniti d'America 21.777
SG - Singapore 3.637
DE - Germania 2.875
CN - Cina 2.448
SE - Svezia 1.752
IT - Italia 1.690
UA - Ucraina 1.599
RU - Federazione Russa 1.084
GB - Regno Unito 1.002
BR - Brasile 977
HK - Hong Kong 945
VN - Vietnam 926
PL - Polonia 836
KR - Corea 685
FI - Finlandia 659
FR - Francia 596
TR - Turchia 567
BG - Bulgaria 295
IE - Irlanda 295
IN - India 218
NL - Olanda 150
CA - Canada 140
AR - Argentina 114
CH - Svizzera 85
BD - Bangladesh 75
MX - Messico 67
ES - Italia 65
ID - Indonesia 55
IQ - Iraq 55
JP - Giappone 50
ZA - Sudafrica 50
SA - Arabia Saudita 49
EC - Ecuador 46
BE - Belgio 40
SN - Senegal 40
EG - Egitto 36
AT - Austria 35
MA - Marocco 35
PH - Filippine 33
CL - Cile 29
CO - Colombia 28
PK - Pakistan 27
EU - Europa 26
KE - Kenya 24
RO - Romania 23
VE - Venezuela 23
GR - Grecia 21
CI - Costa d'Avorio 20
CZ - Repubblica Ceca 20
PT - Portogallo 20
TH - Thailandia 20
JO - Giordania 18
UZ - Uzbekistan 18
AU - Australia 17
RS - Serbia 17
PY - Paraguay 16
TW - Taiwan 15
AZ - Azerbaigian 14
AE - Emirati Arabi Uniti 12
DZ - Algeria 11
GE - Georgia 11
IL - Israele 11
IR - Iran 11
KZ - Kazakistan 11
LT - Lituania 11
NP - Nepal 11
TN - Tunisia 10
UY - Uruguay 10
MY - Malesia 9
HU - Ungheria 8
JM - Giamaica 8
PA - Panama 8
BO - Bolivia 7
HR - Croazia 7
NZ - Nuova Zelanda 7
OM - Oman 7
TT - Trinidad e Tobago 7
BA - Bosnia-Erzegovina 6
DO - Repubblica Dominicana 6
KW - Kuwait 6
PE - Perù 6
SK - Slovacchia (Repubblica Slovacca) 6
KG - Kirghizistan 5
LV - Lettonia 5
PS - Palestinian Territory 5
AL - Albania 4
BH - Bahrain 4
BY - Bielorussia 4
CR - Costa Rica 4
DK - Danimarca 4
EE - Estonia 4
LB - Libano 4
LK - Sri Lanka 4
NG - Nigeria 4
QA - Qatar 4
BW - Botswana 3
GA - Gabon 3
NO - Norvegia 3
SI - Slovenia 3
SY - Repubblica araba siriana 3
Totale 46.756
Città #
Woodbridge 2.419
Ann Arbor 2.344
Singapore 2.197
Fairfield 1.925
Houston 1.770
Ashburn 1.547
Jacksonville 1.397
Chandler 1.137
Wilmington 1.040
San Jose 954
Hong Kong 927
Seattle 792
Hefei 769
Seoul 681
Cambridge 649
Warsaw 547
Princeton 523
Beijing 496
Izmir 494
Boardman 465
Chicago 335
Trieste 320
Ho Chi Minh City 292
Sofia 292
Dublin 285
Munich 268
Zgierz 257
Columbus 253
Lauterbourg 246
Dearborn 222
Santa Clara 213
Hanoi 212
Milan 206
Los Angeles 197
Dallas 187
Moscow 184
Buffalo 168
Helsinki 145
The Dalles 129
San Diego 124
Council Bluffs 92
Düsseldorf 84
Frankfurt am Main 79
Redwood City 73
Verona 72
Bern 70
Mcallen 67
São Paulo 67
Guangzhou 60
London 60
Nanjing 53
Phoenix 51
Mestre 49
Des Moines 48
Montréal 48
New York 48
Orem 44
Rio de Janeiro 41
Dakar 40
Shanghai 40
Haiphong 39
Chennai 38
Da Nang 38
Norwalk 36
Tokyo 36
Kocaeli 34
Kunming 33
Turku 32
Rome 31
Brussels 30
Tianjin 30
Redondo Beach 28
Amsterdam 25
Casablanca 25
Montreal 24
Bremen 23
Atlanta 22
San Francisco 22
Zhengzhou 22
Can Tho 21
Denver 21
Jinan 21
Abidjan 20
Andover 20
Johannesburg 20
Mexico City 20
Wuhan 20
Baghdad 19
Dhaka 19
Hangzhou 19
Jeddah 19
Nairobi 19
Nanchang 19
Ottawa 19
Vienna 19
Brooklyn 18
Manchester 18
Miano 18
Nuremberg 18
Porto Alegre 18
Totale 29.767
Nome #
Chimica Inorganica, seconda edizione italiana condotta sulla quinta edizione inglese 650
Neutral 1,3,5-Triaza-7-phosphaadamantane-Ruthenium(II) Complexes as Precursors for the Preparation of Highly Water-Soluble Derivatives 583
Synthetic strategies towards ruthenium-porphyrin conjugates for anticancer activity 389
New Insight into a Deceptively Simple Reaction: The Coordination of bpy to RuII-Carbonyl Precursors - The Central Role of thefac-[Ru(bpy)Cl(CO)3]+Intermediate and theChloride Rebound Mechanism 376
1-(2-Picolyl)-substituted 1,2,3-triazole as novel chelating ligand for thepreparation of ruthenium complexes with potential anticancer activity 360
New Cationic and Neutral Ru(II)- and Os(II)-dmso carbonyl Compounds 359
Thirty Years of the Drug Candidate NAMI-A and the Myths in the Field of Ruthenium Anticancer Compounds: A Personal Perspective 303
A noncovalently linked, dynamic fullerene porphyrin dyad. Efficient formation of long-lived charge separated states through complex dissociation. 302
Side-to-face ruthenium porphyrin arrays. Photophysical behavior of dimeric and pentameric systems. 299
Palladium complexes with simple iminopyridines as catalysts for polyketone synthesis 288
(15)N NMR spectroscopy unambiguously establishes the coordination mode of the diimine linker 2-(2'-pyridyl)pyrimidine-4-carboxylic acid (cppH) in Ru(II) complexes 276
New salts of anionic complexes of Ru(III) as antimetastatic and antineoplastic agents. 275
Synthesis, Molecular Structure and Chemical Behavior of Hydrogen trans-bis(Dimethylsulfoxide)Tetrachlororuthenate(III) and mer-Trichlorotris(Dimethylsulfoxide)Ruthenium(III) - the First Fully Characterized Chloride Dimethylsulfoxide Ruthenium(III) Complexes 265
A spectroscopic study of the reaction of NAMI, a novel ruthenium(III) anti-neoplastic complex, with bovine serum albumin 263
Design of photoactivatable metallodrugs: Selective and rapid light-induced ligand dissociation from half-sandwich [Ru([9]aneS3)(N–N′)(py)]2+ complexes 262
NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry 261
Complessi dicarbossilati del rutenio(II) e loro impiego come antitumorali 255
A categorization of metal anticancer compounds based on their mode of action. 253
null 252
Rare Example of Stereoisomeric 2 + 2 Metallacycles of Porphyrins Featuring Chiral-at-Metal Octahedral Ruthenium Corners 252
Sulfoxide ruthenium complexes: non toxic tools for the selective treatment of solid tumour metastases. 246
Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy 242
Antitumor action of mer-trichlorobis(dimethyl sulfoxide)aminoruthenium(III) (BBR2382) in mice bearing Lewis lung carcinoma 239
Activation of Rh6(CO)16 with 1,10-phenanthroline and substituted derivatives in the catalytic reduction of nitrobenzene to aniline with carbon monoxide and water 235
Chemical, biological and antitumor properties of ruthenium(II) complexes with dimethylsulfoxide 235
Discrete Supramolecular Assemblies of Porphyrins Mediated by Coordination Compounds 233
The Insertion of Ruthenium into Porphyrins Revisited and Improved: Proof of Concept Results with a Ruthenium(II) Monocarbonyl Compound, and the Spectacular Effect of Propionic Acid 233
Synthesis and characterization of new halogen -tetramethylene sulfoxide-ruthenium(II) and ruthenium(III) complexes; crystal structure of cis-dichlorotetrakis(tetramethylene sulfoxide) ruthenium(II) and hydrogen trans-bis(tetramethylene sulfoxide)tetrachlororuthenate(III) 232
Antitumor properties of ruthenium(II)-dimethylsulfoxide complexes in the Lewis lung carcinoma system 232
Response of MCa mammary carcinoma to cisplatin and to Na[trans-RuCl4(DMSO)(Im)]. 231
Solution and solid state structure of a canted, side-to-face, bis-porphyrin adduct. 229
New atropisomeric bidentate nitrogen-donor compounds as potential stereocontrollers in mild CO-styrene copolymerisation catalysed by palladium(II) salts. 229
The rare head-to-head conformation of untethered lopsided ligands discovered in both solution and solid states of 1,5,6-trimethylbenzimidazole Re(V) and Ru(II) complexes. 229
Influence of the anionic ligands on the anticancer activity of Ru(II)-dmso complexes: Kinetics of aquation and in vitro cytotoxicity of new dicarboxylate compounds in comparison with their chloride precursors 226
The synthesis of RuBr2(DMSO)3 revisited: a mixture of Li[fac-RuClnBr3-n(DMSO)3] isomers (n = 0-3) is the reaction product 225
A novel open-box shaped pentamer of vertically linked porphyrins that selectively recognizes S-bonded Me2SO complexes. 224
Ruthenium(III) complexes as antineoplastic agents. 223
Activation of carbonyl clusters with 1,10-phenanthroline and related ligands: the reduction of nitrobenzene as a model reac¬tion for MX(CO)Y (M = Ru, Os, Ir) + Phen systems as catalyst precursors 222
trans-Ru(II)dimethylsulfoxides: antineoplastic action on mouse tumors 221
NAMI-A is highly cytotoxic toward leukaemia cell lines: evidence of inhibition of KCa 3.1 channels 221
Ruthenium anticancer compounds: challenges and expectations 220
Antitumour properties of dimethylsulphoxide ruthenium (II) complexes in theLewis lung carcinoma system. 220
Carbonyl derivatives of chloride dimethyl-sulfoxide ruthenium(II) complexes. Synthesis, structural characterization, and reactivity of Ru(CO)(X)(Dmso)(4-X)Cl-2 complexes (X=1-3) 220
Wavelength-Dependent Electron and Energy Transfer Pathways in a Side-to-Face Ruthenium Porphyrin / Perylene Bisimide Assembly 219
Tumor inhibition and effects on host survival time by rutheniumIII andrhodiumIII complexes with dimethylsulphoxide ligands. 217
Antineoplastic effects of mer-RuCl3(DMSO)2(NH3) against murine tumors: comparison with cisplatin and with ImH[RuIm2Cl4]. 217
Ruthenium-Porphyrin Conjugates with Cytotoxic and Phototoxic Antitumor Activity 216
Water-Soluble Ruthenium(II) Carbonyls with 1,3,5-Triaza-7-phosphoadamantane 216
Synthesis and Properties of Novel Fullerene Derivatives 215
Phototoxic Activity and DNA Interactions of Water-Soluble Porphyrins and Their Rhenium(I) Conjugates 215
Complexed bridging ligands: oxorhenium(V) compounds with mono-coordinated pyrazine or pyrimidine as possible building-blocks for the construction of polynuclear architectures. 212
Antileukemic action of RuCl2(DMSO)4 isomers and prevention of brain involvement on P388 leukemia and on P388/DDP subline 212
Reduction of lung metastases by Na[trans-RuCl4(DMSO)Im] is not coupled with the induction of chemical xenogenization 211
Coordination and release of NO by ruthenium-dimethylsulfoxide complexes - implications for anti-metastases activity. 210
Antimetastatic action and toxicity on healty tissues of Na[trans-RuCl4(DMSO)Im] in the mouse. 210
New half sandwich-type Ru(II) coordination compounds characterized by the fac-Ru(dmso-S)3 fragment: influence of the face-capping group on the chemical behavior and in vitro anticancer activity. 210
Biophysical analysis of natural, double-helical DNA modified by anticancer heterocyclic complexes of ruthenium(III) in cell-free media 209
Crystals containing conformers: a rare case in which a solid closely reflects a solution equilibrium mixture 208
Efficacy of 5-FU combined to Na[trans-RuCl4(DMSO)(Im)], a novel selective antimetastatic agent, on the survival time of mice with P388 leukemia, P388/DDP subline and MCa mammary carcinoma 208
Complessi di Rutenio con elevata attività antitumorale 208
Synthesis, structural characterization and chemical behavior of new dimeric Ru(III) complexes 208
A Functionalized Noncovalent Macrocyclic Multiporphyrin Assembly from a Dizinc(II) Bis-Porphyrin Receptor and a Free-Base Dipyridylporphyrin 207
COMPLESSI DI Ru(III) COME AGENTI ANTINEOPLASTICI 206
Chemical properties of rare platinum metal complexes having antitumor activity 206
Factors that influence the antiproliferative activity of half sandwich RuII-[9]aneS3 coordination compounds: activation kinetics and interaction with guanine derivatives. 206
Complessi trans di rutenio come agenti antineoplastici 205
Metal-mediated multi-porphyrin discrete assemblies and their photoinduced properties. 205
Synthesis and characterization of a new series of palladium(II) compounds with nitrogen-donor chelating ligands: [Pd(chel)(L)2][PF6]2 205
Porphyrin "flying saucers": Solid state and solution structure of a novelpentameric array of axially-ligated canted porphyrins. 202
Is the aromatic fragment of piano-stool ruthenium compounds an essential feature for anticancer activity? The development of new Ru(II)-[9]aneS3 analogues. 202
Free exchange across cells,and echistatin-sensitive membrane target for the metastasis inhibitor NAMI-A(imidazolium trans-imidazole dimethyl sulfoxide tetrachlororuthenate)ON KB Tumor cells. 202
Geometrical and linkage isomers of OsCl2(dmso)4: the complete picture 202
Antimetastatic properties and DNA interactions of the novel class of dimeric Ru(III) compounds Na2[{trans-RuCl4(Me2SO)}2(μ-L)] (L=ditopic, non-chelating aromatic N-ligand). A preliminary investigation 200
Water-soluble Ru(II)- and Ru(III)-halide-PTA complexes (PTA=1,3,5-triaza-7-phosphaadamantane): Chemical and biological properties 200
Photolabile Ru Model Complexes with Chelating Diimine Ligands for Light-Triggered Drug Release 200
Two-point self-coordination of a dizinc(ii) bis-pyridylporphyrin ruthenium complex leading selectively to a discrete molecular assembly: solution and solid state characterization 199
Antimetastatic action and toxicity on healthy tissues ofNa[trans-RuCl4(DMSO)Im] in the mouse. 198
Structure of trans-dichlorotetrakis(dimethyl sulfoxide)rhodium(III) tetrafluoroborate 198
Rhodium(III) analogues of antitumour-active ruthenium(III) compounds: the crystal structure of [ImH][trans-RhCl4(Im)2] (Im= imidazole) 198
NMR structural characterization of the reaction product between d(GpG) and the octahedral antitumor complex trans-RuCl2(DMSO)4. 197
The development of tumor-inhibiting ruthenium dimethylsulfoxide complexes 197
Photo-active triads self-assembled around a pivot aluminum(III)porphyrin 196
The NAMI A - human ferritin system: a biophysical characterization 195
Energy Transfer Pathways in Pyridylporphyrin Re(I) Adducts. 194
Influence of chemical stability on the activity of the antimetastasis ruthenium compound NAMI-A 192
C60 in the Box. A Supramolecular C60 - Porphyrin Assembly 192
Novel Ru(III)-dimethyl sulfoxide catalysts for the selective oxidation of thioethers to sulfoxides with molecular oxygen 192
Ru(ii)-Peptide bioconjugates with the cppH linker (cppH = 2-(2'-pyridyl)pyrimidine-4-carboxylic acid): synthesis, structural characterization, and different stereochemical features between organic and aqueous solvents 192
Synthesis and characterization of novel Re(I)-Porphyrin dyad and triad for photoinduced electron-transfer 191
Selective hydrogen transfer reactions from alcohols to ketones promoted by rhodium complexes with 1,10-phenanthroline and related ligands 191
Effects of trans-RuCl2 (DMSO)4 on B16 melanoma in mice. 190
Na[trans-RuCl4(DMSO)(Im)]*2DMSO - antimetastatic ruthenium agent 190
Synthesis and Characterization of Two New Classes of Ruthenium(III-Sulfoxide Complexes with Nitrogen Donor Ligands (L) - {$Na\left[\mathit{trans}-RuCl_4(R_2SO)(L)\right]$} and {$\mathit{mer,cis}-RuCl_3(R_2SO)(R_2SO)(L)$} - the crystal structure of {$Na\left[\mathit{trans}-RuCl_4(DMSO)(NH_3)\right]\cdot{}2DMSO$}, {$Na\left[\mathit{trans}-RuCl_4(DMSO)(Im)\right]\cdot{}{H_2O},{Me_2CO}$} (Im=Imidazole) and {$\mathit{mer,cis}-RuCl_3(DMSO)(DMSO)(NH_3)$} 190
Synthesis and Reactivity of Ru-, Os-, Rh-, and Ir-halide-sulfoxide Complexes. 189
Synthesis and characterization of two new classes of ruthenium(III)-sulfoxide complexes with nitrogen donor ligands (L): Na[trans-RuCl4(R2SO)(L)] and mer,cis-RuCl3(R2SO)(R2SO)(L). The crystal structure of Na[trans-RuCl4(DMSO)(NH3)]•2DMSO, Na[trans-RuCl4(DMSO)(Im)]•H2O•Me2CO (Im = imidazole) and mer,cis- RuCl3(DMSO)(DMSO)(NH3) 189
Mixed-ligand rhenium(V) oxo monomers with triphenylphosphine oxide and lopsided and symmetrical heterocyclic ligands. Putative intermediates in rhenium(V) oxo synthetic chemistry 188
The interaction of the antitumor complexes Na[trans-RuCl4(DMSO)(Im)] and Na[trans-RuCl4(DMSO)(Ind)] with apotransferrin: a spectroscopic study 188
Towards Matched Pairs of Porphyrin-ReI/99mTcIConjugates that Combine Photodynamic Activity with Fluorescence and Radio Imaging 188
Carbonyl derivatives of chloride-dimethyl sulfoxide-ruthenium(III) complexes. Synthesis, crystal-structure, and reactivity of [(Dmso)(2)H][Trans-RuCl4(Dmso)(CO)] and mer, cis-RuCl3(Dmso)(2)(CO) 187
Electrochemistry of Sodium trans-bis(Dimethylsulphoxide)Tetrachlororuthenate(III) and mer-Trichlorotris(Dimethylsulphoxide)Ruthenium(III) - the First and Complete Electrochemical Characterization of Chlorodimethyl Sulfoxide Ruthenium(III) Complexes 187
Totale 23.267
Categoria #
all - tutte 130.053
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 130.053


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021989 0 0 0 0 0 0 0 0 0 406 156 427
2021/20223.140 146 232 197 419 70 224 94 125 355 298 213 767
2022/20233.639 373 433 264 440 436 688 32 289 433 23 169 59
2023/20241.907 173 139 91 165 194 107 206 493 15 33 167 124
2024/20255.099 84 311 470 454 463 490 458 373 564 462 369 601
2025/202610.941 957 831 1.091 1.064 933 1.190 1.657 476 1.333 1.409 0 0
Totale 47.642